STAPHYLOCOCCUS AUREUS INTERACTION WITH NEWLY ACQUIRED PSEUDOMONAS AERUGINOSA FROM CYSTIC FIBROSIS PATIENTS UNDERGOING ERADICATION THERAPY

被引：0
|
作者：
Beaudoin, T. [1 ]
Baker, P. [2 ]
Yau, Y. [3 ,4 ]
Parsek, M. [5 ]
Hoffman, L. [6 ]
Howell, L. [2 ,7 ]
Waters, V. J. [1 ,4 ,8 ]
机构：
[1] Univ Toronto, Translat Med, Orangeville, ON, Canada
[2] Hosp Sick Children, Mol Med, Toronto, ON, Canada
[3] Hosp Sick Children, Pediat Lab Med, Toronto, ON, Canada
[4] Univ Toronto, Pathobiol & Lab Med, Toronto, ON, Canada
[5] Univ Washington, Microbiol, Seattle, WA 98195 USA
[6] Univ Washington, Pediat, Seattle, WA 98195 USA
[7] Univ Toronto, Biochem, Toronto, ON, Canada
[8] Hosp Sick Children, Infect Dis, Toronto, ON, Canada
来源：
PEDIATRIC PULMONOLOGY | 2017年 / 52卷
关键词：
D O I：
暂无
中图分类号：
R72 [儿科学];
学科分类号：
100202 ;
摘要：
352
引用
收藏
页码：S349 / S349
页数：1
相关论文
共 50 条
  • [1] Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis
    Cohen-Cymberknoh, Malena
    Gilead, Noa
    Gartner, Silvia
    Rovira, Sandra
    Blau, Hannah
    Mussaffi, Huda
    Rivlin, Joseph
    Gur, Michal
    Shteinberg, Michal
    Bentur, Lea
    Livnat, Galit
    Aviram, Micha
    Picard, Elie
    Tenenbaum, Ariel
    Armoni, Shoshana
    Breuer, Oded
    Shoseyov, David
    Kerem, Eitan
    [J]. JOURNAL OF CYSTIC FIBROSIS, 2016, 15 (06) : 776 - 782
  • [2] THE ROLE OF STAPHYLOCOCCUS AUREUS IN PSEUDOMONAS AERUGINOSA BIOFILM DEVELOPMENT, ANTIBIOTIC SUSCEPTABILITY AND SUCCESS OF ERADICATION THERAPY IN CYSTIC FIBROSIS PATIENTS
    Beaudoin, T.
    Yau, Y.
    Waters, V. J.
    [J]. PEDIATRIC PULMONOLOGY, 2016, 51 : 315 - 315
  • [3] Study of interaction between Staphylococcus aureus and Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis
    Kositska, S.
    Valenza, G.
    Abele-Horn, M.
    Hebestreit, H.
    Ohlsen, K.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2011, 301 : 78 - 78
  • [4] Eradication of Pseudomonas aeruginosa in cystic fibrosis patients
    Döring, G
    Taccetti, G
    Campana, S
    Festini, F
    Mascherini, M
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (03) : 653 - 653
  • [5] Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients
    Taccetti, G
    Campana, S
    Festini, F
    Mascherini, M
    Döring, G
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (03) : 458 - 461
  • [6] Evolution of Staphylococcus aureus in cystic fibrosis patients in the presence of Pseudomonas aeruginosa.
    Kositska, S.
    Valenza, G.
    Abele-Horn, M.
    Hebestreit, H.
    Francois, P.
    Schrenzel, J.
    Ohlsen, K.
    [J]. INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY, 2012, 302 : 78 - 78
  • [7] Sustained Coinfections with Staphylococcus aureus and Pseudomonas aeruginosa in Cystic Fibrosis
    Fischer, Anthony J.
    Singh, Sachinkumar B.
    LaMarche, Mason M.
    Maakestad, Lucas J.
    Kienenberger, Zoe E.
    Pena, Tahuanty A.
    Stoltz, David A.
    Limoli, Dominique H.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (03) : 328 - 338
  • [8] Pseudomonas AerugINOSa Eradication In Adult Cystic Fibrosis Patients
    Nguyen, K.
    Patel, P.
    Fukushmia, L. K.
    Rao, A. P.
    Afshar, K.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189
  • [9] Early Eradication of Pseudomonas aeruginosa in Patients with Cystic Fibrosis
    Stuart, Bridget
    Lin, Jenny H.
    Mogayzel, Peter J., Jr.
    [J]. PAEDIATRIC RESPIRATORY REVIEWS, 2010, 11 (03) : 177 - 184
  • [10] Eradication of Pseudomonas aeruginosa in cystic fibrosis
    Eber, E
    Thalhammer, GH
    Zach, MS
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2006, 27 (02) : 438 - 439
12345